Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
67.90    -0.10 (-0.15%)
Bid:
67.80
Ask:
68.00
Spread: 0.20 (0.295%)
Market Cap: £599.85m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Scrip Dividend Reference Price

6 Jun 2022 08:14

RNS Number : 8069N
IP Group PLC
06 June 2022
 

FOR RELEASE ON

06 June 2022

 

IP Group plc

 Scrip Dividend Reference Price

 

Further to the Company's Annual Results Release on 16 March 2022 and the 2022 AGM Notice which was published on 9 May 2022, the Company announces that the Scrip Reference Share Price for the 2021 Final Dividend, payable on 30 June 2022, is 85.3 pence. Defined terms in this announcement are as defined in the 2022 AGM Notice.

 

The Scrip Reference Share Price is the price at which the Company's Ordinary Shares will be issued and/or Ordinary Shares held in treasury will be sold to shareholders who have elected to receive dividends in the form of fully paid shares in the Company in lieu of cash through participation in the optional Scrip Dividend Scheme, subject to the approval of the applicable resolutions at the 2022 AGM.

 

The Scrip Reference Share Price is the average of the mid-market closing price of the Company's Ordinary Shares, as derived from the London Stock Exchange Daily Official List, for the five dealing days commencing on the relevant ex-dividend date (being 26 May to 01 June 2022).

 

Any shareholder entitled to the 2021 Final Dividend who has not already completed a Scrip Dividend Mandate Form or a Dividend Election Input Message in CREST and is intending to do so, should refer to the Scrip Dividend Scheme Terms and Conditions which can be found at:

https://www.ipgroupplc.com/investor-relations/shareholder-information/scripdividend.

 

The final time and date for receipt of Scrip Dividend Mandates and Dividend Election Input Messages in CREST is 5:00pm on 09 June 2022.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Angela Leach, Company SecretaryLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech. The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBKABDOBKKDAK
Date   Source Headline
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20254:09 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20254:45 pmRNSHolding(s) in Company
10th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20254:51 pmRNSHolding(s) in Company
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20255:14 pmRNSHolding(s) in Company
4th Nov 20256:23 pmRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20255:25 pmRNSTotal Voting Rights
31st Oct 20255:19 pmRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20255:27 pmRNSTransaction in Own Shares
28th Oct 20256:06 pmRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20255:31 pmRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20255:30 pmRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20255:59 pmRNSTransaction in Own Shares
16th Oct 20255:45 pmRNSTransaction in Own Shares
15th Oct 20255:20 pmRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20256:18 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSPotential income from Metsera obesity drugs
10th Oct 20255:17 pmRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNS-RPortfolio co Monolith to be acquired by CoreWeave
7th Oct 20255:21 pmRNSTransaction in Own Shares
6th Oct 20255:56 pmRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20255:23 pmRNSTransaction in Own Shares
30th Sep 20256:05 pmRNSTotal Voting Rights
30th Sep 20256:03 pmRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNS-RPortfolio co OXCCU completes £20.75m funding round
26th Sep 20255:36 pmRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20255:36 pmRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20254:55 pmRNSTransaction in Own Shares
18th Sep 20255:24 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.